Synaptic P2X7 and Oxygen/Glucose Deprivation in Organotypic Hippocampal Cultures

Journal of Cerebral Blood Flow and Metabolism

Volumn 24, Issue 4, 2004, Pages 392-398

  Cavaliere, Fabio ^a   Amadio, Susanna ^a,b   Sancesario, Giuseppe ^a,b   Bernardi, Giorgio ^a,b   Volonté, Cinzia ^a,c  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c CNR   (Italy)

Author keywords

BzATP; Ischemia; Neurofilament; oxATP; P2 receptors; Synaptophysin

Indexed keywords

3' O (4 BENZOYLBENZOYL)ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CIBACRON BLUE F3GA; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; MYELIN BASIC PROTEIN; NEUROFILAMENT PROTEIN; OXYGEN; PURINE ANTAGONIST; PURINE P2X7 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; SYNAPSE RECEPTOR; SYNAPTOPHYSIN; PURINE P2 RECEPTOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN HYPOXIA; BRAIN METABOLISM; CELL DAMAGE; CELL DEATH; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; GENE LOCATION; HIPPOCAMPUS; HYPOGLYCEMIA; IMMUNE SYSTEM; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR UPREGULATION; SENSOR; ANIMAL; BIOSYNTHESIS; CONFOCAL MICROSCOPY; CULTURE MEDIUM; IN VITRO STUDY; METABOLISM; ORGAN CULTURE TECHNIQUE; PATHOLOGY; UPREGULATION; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; BLOTTING, WESTERN; CELL DEATH; CULTURE MEDIA; GLUCOSE; HIPPOCAMPUS; MICROSCOPY, CONFOCAL; ORGAN CULTURE TECHNIQUES; OXYGEN; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; UP-REGULATION;

EID: 1842429176     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200404000-00004     Document Type: Article

References (44)

1. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH (1999) Adenosine triphosphate: established and potential clinical applications. Drugs 58, 211-232
2. Amadio S, D'Ambrosi N, Cavaliere F, Murra B, Sancesario G, Bernardi G, Burnstock G, Volontè C (2002) P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacol 42, 489-501
3. 7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase. J Neurosci 22:5938-5945
4. 7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism. Mol Cell Neurosci 19:272-280
5. Burnstock G (2002) Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin Med 2:45-53
6. Burnstock G, Williams M (2000) P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 295:862-869
7. Cavaliere F, D'Ambrosi N, Ciotti MT, Mancino G, Sancesario G, Bernardi G, Volonté C (2001a) Glucose deprivation and mitochondrial dysfunction: neuroprotection by P2 receptor antagonists. Neurochem Int 38, 189-197
8. Cavaliere F, D'Ambrosi N, Sancesario G, Bernardi G, Volontè C (2001b) Hypolycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue. Neurochem Int 38:199-207
9. Cavaliere F, Sancesario G, Bernardi G, Volontè C (2002) Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: role of P2 and NGFRp75 receptors. J Neurochem 83:1129-1138
10. 4 receptor and ischemic cell death: prevention by P2 antagonists. Neurosci 120:85-98
11. Chen Y, Swanson RA (2003) Astrocytes and brain injury. J Cereb Blood Flow Metab 23:137-149
12. 7 receptor. Neuropharmacol 36:1277-1283
13. Coltman BW, Earley EM, Shahar A, Dudek FE, and Ide CF (1995) Factors influencing mossy fiber collateral sprouting in organotypic slice cultures of neonatal mouse hippocampus. J Comp Neurol 362:209-222
14. Communi D, Dewaste V, Erneux C (1999) Calcium-calmodulin-dependent protein kinase II and protein kinase C-mediated phosphorylation and activation of D-myo-inositol 1,4, 5-trisphosphate 3-kinase B in astrocytes. J Biol Chem 274:14734-14742
15. Czapiga M and Colton CA (1999) Function of microglia in organotypic slice cultures. J Neurosci Res 56:644-651
16. Di Virgilio F (1995) The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today 16:524-528
17. 7 receptor of microglial cells: a novel immunomodulatory receptor. Prog Brain Res 120:355-368
18. 7 receptor-mediated release of excitatory amino acids from astrocytes. J Neurosci 23:1320-1328
19. Evans RJ, Lewis C, Buell G, Valera S, North RA, Surprenant A (1995) Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol Pharmacol 48:178-183
20. Ferrari D, Wesselborg S, Bauer MK, Schulze-Osthoff K (1997) Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65. J Cell Biol 139:1635-1643
21. Ferrari D, Los M, Bauer MK, Vandenabeele P, Wesselborg S, Schulze-Osthoff K (1999) P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett 447:71-75
22. Fields RD, Stevens B (2000) ATP: an extracellular signalling molecule between neurons and glia. Trends Neurosci 23:625-633
23. Frantseva MV, Kokarovtseva L, Perez Velazquez JL (2002) Hypoxia/glucose deprivation-induced brain damage depends on specific gap-junctional coupling. J Cereb Blood Flow Metab 22:453-462
24. Hide I, Tanaka M, Inoue A, Nakajima K, Kohsaka S, Inoue K, Nakata Y (2000) Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J Neurochem 75:965-972.
25. 7 nucleotide receptor. J Biol Chem 275:26792-26798
26. 3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res. 823:183-190
27. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Seguela P, Voigt M, Humphrey PP (2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53, 107-18
28. 7 receptors in neurodegeneration. Eur J Pharmacol 447:261-269
29. 7 Receptors in Ischemic and Excitotoxic Brain Inj In Vivo. J Cereb Blood Flow Metab 23:381-384
30. Murgia M, Hanau S, Pizzo P, Rippa M, Di Virgilio F (1993) Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem. 268:8199-8203
31. 3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J 17:3016-3028
32. Nieber K, Eschke D, Brand A (1999) Brain hypoxia: effects of ATP and adenosine. Prog Brain Res 120:287-297
33. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067
34. North, RA and Barnard EA (1997) Nucleotide receptors. Curr Opin Neurobiol. 7:346-357
35. North RA and Surprenant A (2000) Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40:563-580
36. 7 mediates super oxide production in primary imbroglio and is up regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 278:13309-13317
37. Pellegrini-Giampietro DE, Peruginelli F, Meli E, Cozzi A, Albani-Torregrossa S, Pellicciari R, Moroni F (1999) Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms. Neuropharmacol 38, 1607-1619
38. Phillis JW, O'Regan MH, Perkins LM, (1993) Adenosine 5′ -triphosphate release from the normoxic and hypoxic in vivo rat cerebral cortex. Neurosci Lett 151:94-96
39. Pringle AK, Iannotti F, Wilde GJ, Chad JE, Seeley PJ, Sundstrom LE (1997) Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro hypoxia/glucose deprivation. Brain Res 755:36-46
40. Sanz JM and Di Virgilio F (2000) Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells. J Immunol 164:4893-4898
41. 7 receptors. Am J Physiol 275:F962-971
42. 7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J Neurochem 81:1196-1211
43. Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182
44. Vizi ES (2000) Role of high-affinity receptors and membrane transporters in non-synaptic communication and drug action in the central nervous system. Pharmac Rev 52:63-89